NDAORALTABLET, ORALLY DISINTEGRATING
Approved
Nov 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PROPULSID QUICKSOLV is an orally disintegrating tablet formulation of cisapride monohydrate, a prokinetic agent approved by FDA in 1997. The drug enhances gastric motility and accelerates gastric emptying, making it indicated for gastrointestinal motility disorders. Cisapride works as a serotonin 5-HT4 receptor agonist to facilitate coordinated muscle contractions in the digestive tract.
LOE Approaching
As a product approaching loss of exclusivity with moderate competitive pressure (30%), commercial teams should prepare for generic entry and market contraction.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PROPULSID QUICKSOLV offers experience managing a mature brand through LOE transition, requiring expertise in competitive defense, managed care strategy, and lifecycle extension. This assignment is ideal for professionals developing post-patent commercial acumen and stakeholder management across payers, providers, and competitors.
Brand ManagerSenior Medical Science Liaison
Worked on PROPULSID QUICKSOLV at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.